Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria

American Journal of Human Genetics
Roland KrusePeter Propping

Abstract

Muir-Torre syndrome (MTS) is an autosomal dominant disease defined by the coincidence of at least one sebaceous skin tumor and one internal malignancy. About half of MTS patients are affected by colorectal cancer. In a subgroup of MTS patients the disease has an underlying DNA mismatch-repair (MMR) defect and thus is allelic to hereditary nonpolyposis colorectal cancer (HNPCC). The purpose of this study was to examine to what extent germ-line mutations in DNA MMR genes are the underlying cause of the MTS phenotype. We ascertained 16 MTS patients with sebaceous skin tumors and colorectal cancer, and we examined their skin and visceral tumors for microsatellite instability. All the patients exhibited high genomic instability in at least one tumor. The search for germ-line mutations in the hMSH2 and hMLH1 genes in 13 of the MTS patients revealed truncating mutations in 9 (69%): eight mutations in the hMSH2 gene and one in the hMLH1 gene. This is the first systematic search for germ-line mutations in patients ascertained on the basis of sebaceous skin tumors. Our results indicate that (1) MTS patients exhibit significantly more mutations in the hMSH2 gene than in the hMLH1 gene; and (2) the subpopulation of MTS patients who are als...Continue Reading

References

May 1, 1991·Diseases of the Colon and Rectum·H F VasenH T Lynch
Feb 11, 1988·Nucleic Acids Research·S A MillerH F Polesky
Jun 1, 1986·The American Journal of Dermatopathology·W H BurgdorfA Fahmy
Jul 1, 1995·Journal of the American Academy of Dermatology·R A Schwartz, D P Torre
Jun 1, 1997·The British Journal of Dermatology·C EscheT Ruzicka

❮ Previous
Next ❯

Citations

Dec 12, 2012·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·B GillyJ Welzel
Oct 21, 2010·Der Pathologe·T MentzelA Hartmann
Apr 16, 2010·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N NegraszusE Bertelmann
Feb 3, 2011·Techniques in Coloproctology·V CelentanoL Bucci
Feb 27, 2007·Familial Cancer·Angela ArnoldNatalie Canham
Feb 15, 2005·Clinics in Dermatology·Brian SomoanoHensin Tsao
Feb 28, 2004·Journal of the American Academy of Dermatology·David F FiorentinoSusan M Swetter
Apr 23, 2004·Trends in Molecular Medicine·Roland Kruse, Thomas Ruzicka
Aug 16, 2000·Pediatric Clinics of North America·A J Wyatt, R C Hansen
Mar 28, 2003·Cancer Genetics and Cytogenetics·Carlos SarrocaHenry T Lynch
Sep 13, 2003·Cancer Letters·Masaharu KodaYoshikazu Murawaki
Jul 13, 2002·Trends in Molecular Medicine·Kaichun WeiWinfried Edelmann
Dec 11, 2007·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Vishes ChhibberMeera Mahalingam
Nov 30, 2006·Nature Clinical Practice. Gastroenterology & Hepatology·Andrew M Kaz, Teresa A Brentnall
Apr 19, 2000·The American Journal of Dermatopathology·N Misago, Y Narisawa
Nov 9, 2004·The Cancer Journal·Ellen T MatloffChristina M Chimera
Feb 4, 2006·The American Journal of Dermatopathology·A NishizawaA Yamamoto
Jun 14, 2008·The American Journal of Surgical Pathology·Rajenda S SinghAlexander J F Lazar
Nov 8, 2005·Journal of Medical Genetics·D A LeeJ T Celebi
Jun 19, 2010·Gut and Liver·Eunjeong Jang, Daniel C Chung
Apr 22, 2004·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Cynthia R HarringtonSusan M Swetter
Aug 23, 2001·Proceedings of the National Academy of Sciences of the United States of America·N ZanesiK Huebner
Apr 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·L Y FongK Huebner
Nov 6, 2008·Archives of Dermatological Research·M M van RossumN Hoogerbrugge
Jul 9, 2002·Journal of Cutaneous Pathology·Mahmoud R Hussein, Gary S Wood
Feb 5, 2013·Familial Cancer·Kimberly C BanksKristen J Vogel
Feb 20, 2016·Journal of the American Academy of Dermatology·Prajakta D JajuKavita Y Sarin
Dec 11, 2013·American Journal of Ophthalmology·Anand Rajan KdCharles G Eberhart
Oct 15, 2013·Seminars in Ophthalmology·Ching-Yuen WongRaymond Kwok-Kay Tse
Nov 16, 2010·Hematology/oncology Clinics of North America·Neel B Shah, Noralane M Lindor
Mar 5, 2016·Cancer Metastasis Reviews·Aleš Ryška
Jun 15, 2010·Clinics in Dermatology·Christine J Ko
Sep 16, 2009·Journal of the American Academy of Dermatology·Daniel B Eisen, Daniel J Michael
Sep 16, 2009·Journal of the American Academy of Dermatology·Daniel B Eisen, Daniel J Michael
Sep 8, 2009·Gastroenterology·Stefanie VogtStefan Aretz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.